ATC Group: S01GX08 Ketotifen

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01GX08 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01G Decongestants and antiallergics
4 S01GX Other antiallergics
5 S01GX08 Ketotifen

Active ingredients in S01GX08

Active Ingredient Description
Ketotifen

Ketotifen is a histamine H1-receptor antagonist. In vivo animal studies and in vitro studies suggest the additional activities of mast cell stabilisation and inhibition of infiltration, activation and degranulation of eosinophils.

Related product monographs

Title Information Source Document Type  
KETOFALL Eye drops, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
ZADITEN Eye drops, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
ZADITEN Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Italy (IT)

Japan (JP)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.